Development of C646‐Based Proteolysis Targeting Chimeras Degraders of the Lysine Acetyltransferases CBP and p300
Francesco Fiorentino(Sapienza University of Rome), Antonello Mai(Sapienza University of Rome)
Cited by 3
Related Papers
RETRACTED ARTICLE: Dissecting the role of novel EZH2 inhibitors in primary glioblastoma cell cultures: effects on proliferation, epithelial-mesenchymal transition, migration, and on the pro-inflammatory phenotype
|Clinical Epigenetics|2019|61
First-in-Class Selective Inhibitors of the Lysine Acetyltransferase KAT8
|Journal of Medicinal Chemistry|2023|21